|
Market Closed -
Other stock markets
|
After hours 08:00:00 pm | |||
| 1,094.44 USD | -1.08% |
|
1,071.54 | -2.09% |
| Jun. 23 | Thalia Therapeutics eyes adding microRNA therapeutic asset | AN |
| Jun. 23 | Goldman Sachs' Equities Business on Track to Generate Over $5 Billion in Revenue in Q2 | MT |
| Market Cap | 336B 295B 272B 254B 476B 31,787B 484B 3,262B 1,263B 15,596B 1,260B 1,233B 54,207B | P/E 2026 * |
18.4x | P/E 2027 * | 16.7x |
|---|---|---|---|---|---|
| Enterprise Value | 769B 676B 623B 583B 1,092B 72,881B 1,111B 7,478B 2,895B 35,759B 2,888B 2,826B 124,285B | EV / Sales 2026 * |
12x | EV / Sales 2027 * | 11.7x |
| Free-Float |
31.35% | Yield 2026 * |
1.68% | Yield 2027 * | 1.81% |
Last Transcript: The Goldman Sachs Group, Inc.
| 1 day | -1.08% | ||
| 1 week | +0.35% | ||
| Current month | +6.72% | ||
| 1 month | +9.80% | ||
| 3 months | +31.66% | ||
| 6 months | +21.37% | ||
| Current year | +24.51% |
| 1 week | 1,069 |  | 1,125 |
| 1 month | 974.42 | | 1,125 |
| Current year | 780.5 | | 1,125 |
| 1 year | 660.78 | | 1,125 |
| 3 years | 289.36 | | 1,125 |
| 5 years | 277.84 | | 1,125 |
| 10 years | 130.85 | | 1,125 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Solomon
CEO | Chief Executive Officer | 64 | 2018-09-30 |
John Waldron
PSD | President | 57 | 2018-09-30 |
Denis Coleman
DFI | Director of Finance/CFO | 53 | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
David Viniar
BRD | Director/Board Member | 70 | 2012-12-31 |
M. Burns
BRD | Director/Board Member | 68 | 2011-10-26 |
| Director/Board Member | 63 | 2014-03-02 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| May. 13 | Sell | Chief Financial Officer | -6,857 | 0.0023% | ||
| May. 05 | Sell | General Counsel | -14,292 | 0.0048% | ||
| Apr. 30 | Sell | Controller/Auditor | -10,301 | 0.0035% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.08% | +0.35% | +69.19% | +247.76% | 336B | |
| -0.47% | +2.35% | +68.68% | +170.44% | 357B | |
| -0.48% | +1.38% | +82.67% | +215.02% | 247B | |
| +1.24% | -0.53% | +5.42% | +75.23% | 162B | |
| -1.12% | +3.93% | +7.97% | +42.67% | 60.24B | |
| -0.73% | +4.43% | +109.06% | +199.11% | 28.75B | |
| -4.61% | -2.91% | +19.66% | +50.82% | 29.59B | |
| -0.23% | +3.86% | +24.50% | +54.25% | 26.37B | |
| +0.82% | -2.65% | +57.19% | +161.09% | 25.35B | |
| +2.29% | +6.18% | +20.14% | +47.79% | 24.81B | |
| Average | -0.45% | +2.67% | +46.45% | +126.42% | 129.65B | |
| Weighted average by Cap. | -0.47% | +2.40% | +58.48% | +174.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.98B 56.21B 51.79B 48.48B 90.84B 6,061B 92.37B 622B 241B 2,974B 240B 235B 10,336B | 67.07B 58.92B 54.29B 50.83B 95.23B 6,354B 96.83B 652B 252B 3,117B 252B 246B 10,835B |
| Net income | 18.12B 15.92B 14.67B 13.73B 25.73B 1,717B 26.17B 176B 68.19B 842B 68.04B 66.57B 2,928B | 19.41B 17.05B 15.71B 14.71B 27.56B 1,839B 28.02B 189B 73.03B 902B 72.87B 71.3B 3,136B |
| Net Debt | 434B 381B 351B 329B 616B 41,094B 626B 4,217B 1,632B 20,163B 1,629B 1,593B 70,079B | 450B 395B 364B 341B 638B 42,598B 649B 4,371B 1,692B 20,900B 1,688B 1,652B 72,642B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-23 | $1,094.44 | -1.08% | 2,066,874 |
| 26-06-22 | $1,106.37 | +0.89% | 1,894,803 |
| 26-06-18 | $1,096.56 | -0.23% | 4,499,162 |
| 26-06-17 | $1,099.14 | +0.78% | 2,180,014 |
| 26-06-16 | $1,090.67 | +1.35% | 1,965,515 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GS Stock
Select your edition
All financial news and data tailored to specific country editions
